GlobeNewswire
NervGen Pharma to Present at Unite2Fight Paralysis’ 20th Annual Science and Advocacy Symposium
📈
AI Sentiment
Highly Positive
9/10
NervGen Pharma Corp. Common stock News
Latest updates and market news for NGEN
3 news
Feb 8 - Feb 14, 2026
Page 1
GlobeNewswire
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
📈
AI Sentiment
Highly Positive
9/10
Share this news page